Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 4Active not recruiting 3Recruiting 2Not yet recruiting 2Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Thoracic 1Myeloid 1Genitourinary 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 2Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1

Interventions

venetoclax 38Azacitidine 24fludarabine 20Cytarabine 18Cyclophosphamide 16Specimen Handling 14blinatumomab 13Biopsy 12Busulfan 8Dexamethasone 7Melphalan 6Daunorubicin 6Whole-Body Irradiation 5Vincristine 5Thiotepa 5Methotrexate 5Decitabine 5gilteritinib 4daratumumab 4Tacrolimus 4Stem Cell Transplantation 4Magnetic Resonance Spectroscopy 4Imatinib Mesylate 4Idarubicin 4Exercise 4Blood Specimen Collection 4zanubrutinib 3selinexor 3ruxolitinib 3revumenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Maintenance × Other hematologic neoplasm × Clear all
NCT07572929 2026-05-07

PREeMPT

Medical College of Wisconsin

Phase 2 Not yet recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07407140 2026-03-25

VAG-3+7-G

Institute of Hematology & Blood Diseases Hospital, China

Phase 3 Not yet recruiting
300 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡